Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 30/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

44%

4 trials in Phase 3/4

Results Transparency

60%

3 of 5 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

Phase 3
4(57.1%)
N/A
3(42.9%)
7Total
Phase 3(4)
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT06650397Not ApplicableCompleted

Guatemala Biofortified Maize Study

Role: collaborator

NCT06723392Phase 3Recruiting

Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries

Role: collaborator

NCT06080451Not ApplicableCompleted

Implementing HEARTS in Guatemala

Role: collaborator

NCT03871491Phase 3Completed

Azithromycin-Prevention in Labor Use Study (A-PLUS)

Role: collaborator

NCT05590260Phase 3Unknown

Prevention of Iron Deficiency Anemia Post-delivery

Role: collaborator

NCT03504124Phase 3Completed

Multicomponent Intervention to Improve Hypertension Control in Central America

Role: lead

NCT04438200Unknown

Liver and Bone Retinol Levels in Guatemalan Adolescents and Adults

Role: collaborator

NCT03345147Completed

Estimation of Vitamin A Stores in Children and Women in Guatemala and Relation With Potential Toxicity Markers

Role: lead

NCT01295216Not ApplicableTerminated

Use of Mobile Technology to Prevent Progression of Pre-hypertension in Latin American Urban Settings

Role: lead

All 9 trials loaded